The largest database of trusted experimental protocols

L thyroxin t4

Manufactured by Merck Group
Sourced in Japan

L-thyroxin (T4) is a laboratory product manufactured by Merck Group. It is the main thyroid hormone produced by the thyroid gland. L-thyroxin is used in biochemical and medical research to study thyroid function and metabolism.

Automatically generated - may contain errors

2 protocols using l thyroxin t4

1

Thyroxin Supplementation in Hypoxia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were randomly divided into 4 groups by a research assistant blind to the experiments. To determine the sample size, we set a power value of around 90%, and we also determined the direction of the effect as two tailed with α level = 0.05, δ mean = 1.2, σ2 = 0.64, and attrition around 1%. We then calculated the sample size using the following formula: N = 2σ2(Zα + Z1 − β)2/(μ1 − μ2)2 = 9.33.
Note: σ2 = 0.64; (μ1 − μ2)2 = δ mean = 1.2; Zα = 1.96; Z1 − β = 1.28, which were determined by a standard normal distribution table.
The corrected sample size = sample size/(1% attribution of animal) = 9/0.9 = 10. However, statistical significance was observed with 9 pups, so we used only 9 rat pups for each group in this experiment. Eight rats were treated with 0.2 mg/kg L-thyroxin (T4; Sigma, Kawasaki, Japan) (HI+low T4 group), 9 rats were administered 1 mg/kg T4 (HI+high T4 group), and 9 animals were injected with normal saline (NS). T4 or NS was injected intraperitoneally 48 to 96 h after hypoxia. Eight pups received a sham operation (sham controls). While T4 treatment reduced body weight, there was no significant difference between groups on postnatal day (P) 7, P9, and P11.
+ Open protocol
+ Expand
2

Inducing Thyroid Dysfunction in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treatment was started on day 21 of weaning and lasted for four consecutive weeks. Rats were randomly divided into three groups, with ten rats in each group. The first group of rats served as the control. The second group (hypo-T) received 0.05% 6-propyl-2-thiouracil (PTU, Sigma-Aldrich, St. Louis, MO, USA) in drinking water for four weeks to induce hypothyroidism, and PTU was used to inhibit thyroxin secretion and induce hypothyroidism. The third group (hyper-T) was treated with L-thyroxin (T4, Sigma-Aldrich). T4 was dissolved in 0.1 mM sodium hydroxide (NaOH) solution and diluted in physiological saline, and then was administered to rats by daily subcutaneous injections of 20 µg/100 g body weights for the same period to induce hyperthyroidism. Notably, the doses of PTU and T4 were selected on the basis of our previous study [8 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!